WallStreetZenWallStreetZen

NYSE: PEN
Penumbra Inc Stock Forecast, Predictions & Price Target

OverviewForecast
EarningsDividendOwnership

Analyst price target for PEN

Based on 9 analysts offering 12 month price targets for Penumbra Inc.
Min Forecast
$250.00+10.32%
Avg Forecast
$333.00+46.95%
Max Forecast
$376.00+65.92%

Should I buy or sell PEN stock?

Based on 9 analysts offering ratings for Penumbra Inc.
Strong Buy
Strong Buy
8 analysts 88.89%
Buy
1 analysts 11.11%
Hold
0 analysts 0%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%

Be the first to know when Wall Street analysts revise their PEN stock forecasts and price targets.

PEN stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
lockedlocked$00.00+00.00%2023-11-03
lockedlocked$00.00+00.00%2023-11-03
lockedlocked$00.00+00.00%2023-10-02
lockedlocked$00.00+00.00%2023-08-17
lockedlocked$00.00+00.00%2023-08-02
Truist Securities
Bottom 15%
15
Strong BuyMaintains$345.00+53.63%2023-08-02
Wells Fargo
Top 17%
84
Strong BuyMaintains$337.00+50.06%2023-08-02Find out why
Truist Securities
Top 13%
88
Strong BuyMaintains$370.00+64.76%2023-07-19Find out why
Deutsche Bank
Top 37%
64
Strong BuyMaintains$376.00+67.43%2023-06-26Find out why
BTIG
Top 6%
95
Strong BuyMaintains$328.00+46.06%2023-06-05Find out why

1 of 1

Forecast return on equity

Is PEN forecast to generate an efficient return?
Company
N/A
Industry
20.77%
Market
39.73%

Forecast return on assets

Is PEN forecast to generate an efficient return on assets?
Company
N/A
Industry
10.69%

PEN revenue forecast

What is PEN's revenue in the next 3 years based on estimates from 7 analysts?
Avg 1 year Forecast
$1.1B+6.64%
Avg 2 year Forecast
$1.3B+27.39%
Avg 3 year Forecast
$1.5B+46.29%
PEN's revenue is forecast to... subscribe to Premium to read more.
Forecast High Revenue Growth Forecast

PEN earnings growth forecast

How is PEN forecast to perform vs Medical Devices companies and vs the US market?
Company
32.47%
Industry
37.99%
Market
21.3%
PEN's earnings are forecast to... subscribe to Premium to read more.
Forecast Earnings Growth vs Industry Forecast
PEN's earnings are forecast to... subscribe to Premium to read more.
Forecast Earnings Growth vs Market Forecast
PEN's earnings are forecast to... subscribe to Premium to read more.
Forecast Earnings Growth vs Savings Rate Forecast

PEN revenue growth forecast

How is PEN forecast to perform vs Medical Devices companies and vs the US market?
Company
12.59%
Industry
5.7%
Market
6.55%
PEN's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Industry Forecast
PEN's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Market Forecast

PEN vs Medical Device Stocks

TickerPricePrice TargetUp/downsideConsensus
PEN$224.57$333.00+48.28%Strong Buy
BIO$304.40$524.50+72.31%Strong Buy
BRKR$64.16$65.00+1.31%Hold
GMED$44.89$64.33+43.31%Buy
SWAV$166.98$255.20+52.83%Buy
View Top Medical Device Stocks

Penumbra Stock Forecast FAQ

Is Penumbra Stock a good buy in 2023, according to Wall Street analysts?

The consensus among 9 Wall Street analysts covering (NYSE: PEN) stock is to Strong Buy PEN stock.

Out of 9 analysts, 8 (88.89%) are recommending PEN as a Strong Buy, 1 (11.11%) are recommending PEN as a Buy, 0 (0%) are recommending PEN as a Hold, 0 (0%) are recommending PEN as a Sell, and 0 (0%) are recommending PEN as a Strong Sell.

If you're new to stock investing, here's how to buy Penumbra stock.

What is PEN's revenue growth forecast for 2023-2025?

(NYSE: PEN) Penumbra's forecast annual revenue growth rate of 12.59% is forecast to beat the US Medical Devices industry's average forecast revenue growth rate of 5.7%, and it is also forecast to beat the US market's average forecast revenue growth rate of 6.55%.

Penumbra's revenue in 2023 is $995,059,000.On average, 7 Wall Street analysts forecast PEN's revenue for 2023 to be $40,956,379,395, with the lowest PEN revenue forecast at $40,834,955,228, and the highest PEN revenue forecast at $41,031,140,556. On average, 7 Wall Street analysts forecast PEN's revenue for 2024 to be $48,924,290,385, with the lowest PEN revenue forecast at $47,389,274,313, and the highest PEN revenue forecast at $49,673,523,042.

In 2025, PEN is forecast to generate $56,183,417,710 in revenue, with the lowest revenue forecast at $53,754,008,048 and the highest revenue forecast at $56,916,710,067.

What is PEN's forecast return on assets (ROA) for 2023-2025?

(NYSE: PEN) forecast ROA is N/A, which is lower than the forecast US Medical Devices industry average of 10.69%.

What is PEN's Price Target?

According to 9 Wall Street analysts that have issued a 1 year PEN price target, the average PEN price target is $333.00, with the highest PEN stock price forecast at $376.00 and the lowest PEN stock price forecast at $250.00.

On average, Wall Street analysts predict that Penumbra's share price could reach $333.00 by Nov 3, 2024. The average Penumbra stock price prediction forecasts a potential upside of 48.28% from the current PEN share price of $224.57.

What is PEN's forecast return on equity (ROE) for 2023-2025?

(NYSE: PEN) forecast ROE is N/A, which is considered weak.
©2023 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.